Press Releases

Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division

The Facility acquisition positions Havn Life to quickly expand its product portfolio and reach additional NHP categories. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce, further to …

Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division Read More »

Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness

Havn Life believes operations can advance its business plan and potentially accelerate production of naturally-derived psilocybin for global medical research. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, has …

Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness Read More »

Havn Life CEO to Present at Zooming With LD, a Leading Platform for Microcap Companies

CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM PT/ 11:00 AM ET Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, announced today that it will …

Havn Life CEO to Present at Zooming With LD, a Leading Platform for Microcap Companies Read More »

Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer

Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer

Pozar will lead sales, marketing, e-commerce and logistics for Havn Retail Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FRA: 5NP) (FSE: 5NP)  (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that industry veteran Jenna Pozar …

Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer Read More »

Havn Life Sciences to Host Investor Webcast on March 3, 2021

Attendees will have the opportunity to get the latest updates and participate in Q & A with Havn Life CEO Tim Moore Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare …

Havn Life Sciences to Host Investor Webcast on March 3, 2021 Read More »

Havn Life announces DTC Eligibility of Its Common Shares in the United States

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce today that its common shares are now eligible for electronic clearing and settlement through the Depository Trust …

Havn Life announces DTC Eligibility of Its Common Shares in the United States Read More »

Havn Life Announces Changes to Board Composition and Departure of Ms. Rasode

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), announces the departure of Ms. Barinder Rasode as President and as a director of the Company, effective immediately. The Company also announces that its Chief Executive Officer, Mr. Tim Moore, has been appointed as a director of …

Havn Life Announces Changes to Board Composition and Departure of Ms. Rasode Read More »

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Havn Life to supply psychedelic compounds for clinical trials launched by neuroscience and technology leader HealthTech Connex Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce …

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc. Read More »

Havn Life Sciences Enters Definitive Agreement to Acquire Strategic Manufacturing & Packaging Facility for its Retail Division

Havn Life Sciences Enters Definitive Agreement to Acquire Strategic Manufacturing & Packaging Facility for its Retail Division

The acquisition is intended to vertically integrate the Company’s retail manufacturing capabilities to support the growth of its nutraceutical division and deliver unique products to consumers. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the …

Havn Life Sciences Enters Definitive Agreement to Acquire Strategic Manufacturing & Packaging Facility for its Retail Division Read More »

Havn Life Grants Stock Options and Restricted Share Rights

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”) announces that it has granted 250,000 incentive stock options (the “Options”) at an exercise price of $0.85 per common share for a five year term. Further, the Company has granted 50,000 restricted share rights (the “RSRs”) with …

Havn Life Grants Stock Options and Restricted Share Rights Read More »

Scroll to Top